Eddiemar Ortiz Cruz
Hematology & Oncology · San Juan, PRNPI 1578710422
Payments from drug & device makers
Across 496 payments — averaging $21.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- E.r. Squibb & Sons, L.L.C.$2K
- Eli Lilly Export S.A. Puerto Rico Branch$1K
- PBG Puerto Rico LLC$1K
- AstraZeneca$1K
- AbbVie$630
- plus $3K from 27 others
What the payments were for
- Food & beverage$9,43387%
- Education$1,36613%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 98 | $2,211 |
| E.r. Squibb & Sons, L.L.C. | 99 | $1,586 |
| Eli Lilly Export S.A. Puerto Rico Branch | 33 | $1,140 |
| PBG Puerto Rico LLC | 56 | $1,108 |
| AstraZeneca(2 entities) | 45 | $1,103 |
| AbbVie | 30 | $630 |
| Merck | 28 | $519 |
| Incyte Corporation | 10 | $309 |
| Sanofi | 11 | $287 |
| Sobi, Inc | 9 | $223 |
| Genentech USA, Inc. | 9 | $198 |
| Amgen | 8 | $156 |
| Regeneron Healthcare Solutions, Inc. | 6 | $128 |
| Rigel Pharmaceuticals, Inc. | 5 | $128 |
| Clovis Oncology, Inc. | 6 | $125 |
| Sun Pharmaceutical Industries Inc. | 3 | $116 |
| Verity Pharmaceuticals Inc. | 4 | $103 |
| Pfizer | 3 | $101 |
| Bayer | 6 | $93 |
| Lilly USA, LLC | 4 | $84 |
| Bayer Puerto Rico Inc. | 3 | $77 |
| Gilead(2 entities) | 2 | $62 |
| Eisai Inc. | 4 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Novartis | 2 | $39 |
| Puma Biotechnology, Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Taiho Oncology, Inc. | 2 | $24 |
| EMD Serono, Inc. | 1 | $18 |
| Exelixis Inc. | 1 | $18 |
| ADC Therapeutics America, Inc. | 1 | $17 |
| Beone Medicines USA, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$10,798 in reported general payments places this provider in the 40th percentile of 138 hematology & oncology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImbruvicaIbrutinib | 68 | $1,138,650 |
| RevlimidLenalidomide | 42 | $903,325 |
| PromactaEltrombopag Olamine | 50 | $649,451 |
| RetacritEpoetin Alfa-Epbx | 81 | $388,350 |
| JakafiRuxolitinib Phosphate | 30 | $366,075 |
| XtandiEnzalutamide | 25 | $321,735 |
| PomalystPomalidomide | 13 | $301,495 |
| ErleadaApalutamide | 15 | $222,985 |
| VenclextaVenetoclax | 13 | $197,642 |
| Lupron DepotLeuprolide Acetate | 36 | $149,771 |
| SprycelDasatinib | 11 | $118,647 |
| Lenalidomide | 12 | $91,980 |
| PerjetaPertuzumab | 13 | $91,375 |
| ProliaDenosumab | 46 | $81,312 |
| HerceptinTrastuzumab | 15 | $70,129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisPromacta | $39 | $649,45150 claims |
| E.r. Squibb & Sons, L.L.C.Pomalyst, Sprycel | $1,586 | $420,14224 claims |
| PfizerRetacrit, Eliquis | $101 | $399,781100 claims |
| Incyte CorporationJakafi | $309 | $366,07530 claims |
| AbbVieVenclexta, Lupron Depot, Synthroid | $630 | $348,25066 claims |
| Johnson & JohnsonErleada | $2,211 | $222,98515 claims |
| AmgenProlia | $156 | $81,31246 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 138 hematology & oncology providers in Puerto Rico.
Other hematology & oncology in San Juan
- Mirelis AcostaSan Juan$6.3M
- Luis FloresSan Juan$2.3M
- Noridza Rivera RodriguezSan Juan$2.1M
- Adelba Torres-LopezSan Juan$1.9M
- Jose Lozada CostasSan Juan$934K
- Fernando CabanillasSan Juan$916K
- Alexis Cruz ChaconSan Juan$505K
- Luis Baez VallecilloSan Juan$350K
- Cristian Rodriguez ArochoSan Juan$227K
- Josselyn Molina AvilaSan Juan$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.